4

4Basebio PLC
LSE:4BB

Watchlist Manager
4Basebio PLC
LSE:4BB
Watchlist
Price: 607.45 GBX 2.96%
Market Cap: 94.4m GBX

Net Margin
4Basebio PLC

-810%
Current
-1 431%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-810%
=
Net Income
-14.4m
/
Revenue
1.8m

Net Margin Across Competitors

No Stocks Found

4Basebio PLC
Glance View

Market Cap
94.1m GBX
Industry
Biotechnology

4basebio Plc develops gene therapy technologies and solutions. The firm is engaged in developing next generation gene therapy technologies and solutions. The firm is focused on supplying therapeutic deoxyribonucleic (DNA) for gene therapies and DNA vaccines and also for providing solutions for delivery of the DNA based products to patients. The firm focuses to manufacture and supply synthetic DNA for research, therapeutic and pharmacological use. Its TruePrime DNA amplification technology is a primer free DNA amplification method using enzymes. Its Hermes is a non-viral delivery platform that can be used to deliver various payloads, ranging from DNA to small interfering ribonucleic acid (siRNA), as well as protein cargoes. The company also offers a messenger ribonucleic acid (mRNA) production service from the DNA template it makes. The company offers a range of services including production of synthetic DNA and RNA payloads, design and assembly of payloads in nanoparticles.

4BB Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-810%
=
Net Income
-14.4m
/
Revenue
1.8m
What is the Net Margin of 4Basebio PLC?

Based on 4Basebio PLC's most recent financial statements, the company has Net Margin of -810%.

Back to Top